26 results
Thumbnail

D2.422 - Supporting second victims: linkages between patient safety and well-being of healthcare workers in allergy departments

Thumbnail

D2.423 - Occupational sensitisation to Chrysonilia sitophila in an asthmatic patient with nasal polyposis

Thumbnail

D2.424 - Allergenic and inflammatory response of combined exposure of shrimp tropomyosin and microbial components in vitro

Thumbnail

D2.425 - Prevalence of Latex Sensitization Among Nursing Staff in Intensive Care Units at the Hospital Universitario Austral: Comparative Analysis and Associated Factors

Thumbnail

D2.426 - Occupational Asthma Due to Tenebrio Molitor in the Owner of a Mealworm Farm: A Case Report

Thumbnail

D2.428 - Asthma severity and work exposure in 66 patient reffered to occupational and allergy unit

Thumbnail

D2.429 - Biologic Therapy in Occupational Asthma: A Multicenter Retrospective Study on Treatment Outcomes and Occupational Impact

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study

Thumbnail

D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy

Thumbnail

D3.395 - Evaluation for suspected penicillin allergy - the patient perspective

Thumbnail

D3.398 - Food provision experience of inpatients with adverse food reactions in the acute hospital setting

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis